| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1064217212 |
| P356 | DOI | 10.1203/00006450-200003000-00004 |
| P8608 | Fatcat ID | release_z4yuyt3lw5gh3px3qppuvptepa |
| P698 | PubMed publication ID | 10709727 |
| P2093 | author name string | Dougherty J | |
| Sharma S | |||
| Hanna N | |||
| Balkundi DR | |||
| Hileb M | |||
| P2860 | cites work | Prevention of allogeneic fetal rejection by tryptophan catabolism | Q24336018 |
| Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions | Q28282106 | ||
| Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand | Q28513283 | ||
| The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis | Q29618601 | ||
| The Fas death factor | Q29620461 | ||
| Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity | Q33488225 | ||
| TNFalpha regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation | Q33688721 | ||
| Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis | Q34065286 | ||
| Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease | Q34602392 | ||
| Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover | Q36236704 | ||
| Metalloproteinase-mediated release of human Fas ligand | Q36365559 | ||
| The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand | Q36367323 | ||
| Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity | Q36400613 | ||
| CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival | Q37362984 | ||
| Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? | Q37364901 | ||
| The expression of Fas Ligand by macrophages and its upregulation by human immunodeficiency virus infection. | Q39805021 | ||
| Fas and Fas ligand: lpr and gld mutations | Q40398275 | ||
| Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? | Q40841827 | ||
| Cytokine networking in the placenta | Q40843926 | ||
| A vision of cell death: insights into immune privilege | Q40898578 | ||
| Fas and FasL in the homeostatic regulation of immune responses | Q40957267 | ||
| Regulation of the proinflammatory effects of Fas ligand (CD95L). | Q40992162 | ||
| Downregulation of Fas ligand by shedding | Q41071790 | ||
| Protection from natural killer cell-mediated lysis by HLA-G expression on target cells | Q41156792 | ||
| Th1-type immunity is incompatible with successful pregnancy | Q41632972 | ||
| Fas ligand mediates activation-induced cell death in human T lymphocytes | Q42942730 | ||
| Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells | Q46642536 | ||
| Purification, Characterization, andin vitroDifferentiation of Cytotrophoblasts from Human Term Placentae* | Q56794799 | ||
| Tumor necrosis factor in preterm and term labor. | Q57081409 | ||
| Epression of the Apoptosis-Inducing FAS Ligand (FASL) in Human First and Third Trimester Placenta and Choriocarcinoma Cells | Q57795082 | ||
| A role for CD95 ligand in preventing graft rejection | Q59066471 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 301-308 | |
| P577 | publication date | 2000-03-01 | |
| P1433 | published in | Pediatric Research | Q7159215 |
| P1476 | title | Labor-associated changes in Fas ligand expression and function in human placenta | |
| P478 | volume | 47 |
| Q33573322 | AKT controls human first trimester trophoblast cell sensitivity to FAS-mediated apoptosis by regulating XIAP expression |
| Q74312978 | Deficiency of decidual IL-10 in first trimester missed abortion: a lack of correlation with the decidual immune cell profile |
| Q35109663 | Endometriosis node in gynaecologic scars: a study of 17 patients and the diagnostic considerations in clinical experience in tertiary care center. |
| Q24681516 | Expression of RCAS1 and FasL in human trophoblasts and uterine glands during pregnancy: the possible role in immune privilege |
| Q50485638 | Is apoptosis a regulatory mechanism during early canine pregnancy? |
| Q44885202 | Labor promotes neonatal neutrophil survival and lipopolysaccharide responsiveness |
| Q47968611 | Regulation of FasL/Fas in Human Trophoblasts: Possible Implications for Chorioamnionitis1 |
| Q44608411 | Resistance to Fas-mediated cell death in BeWo and NJG choriocarcinoma cell lines: implications in immune privilege |
| Q74431078 | Shed membrane fragment modulation of CD3-zeta during pregnancy: link with induction of apoptosis |
| Q24812299 | The placental RCAS1 expression during stillbirth |
| Q36464946 | The possible correlation between the patient's immune tolerance level during cesaerean section and the incidence of subsequent emergency peripartum hysterectomy |
| Q44819588 | The regulation of interleukin-6 secretion by prostanoids and members of the tumor necrosis factor superfamily in fresh villous fragments of term human placenta |
| Q36327217 | The role of Fas mediated apoptosis in preeclampsia |
| Q39382358 | The unique immunological and microbial aspects of pregnancy |
Search more.